Nissen SE - Search Results

1

Nicholls SJ, Uno K, Kataoka Y, Nissen SE. Nicholls SJ, et al. Among authors: nissen se. Expert Opin Biol Ther. 2011 Mar;11(3):387-94. doi: 10.1517/14712598.2011.557061. Epub 2011 Jan 28. Expert Opin Biol Ther. 2011. PMID: 21271950 Review.

2

Impact of intravascular ultrasound in understanding transplant coronary artery disease.

Kapadia SR, Nissen SE, Tuzcu EM. Kapadia SR, et al. Among authors: nissen se. Curr Opin Cardiol. 1999 Mar;14(2):140-50. doi: 10.1097/00001573-199903000-00011. Curr Opin Cardiol. 1999. PMID: 10191973 Review.

3

Application of intravascular ultrasound imaging in understanding and guiding percutaneous therapy for atherosclerotic coronary disease.

Ziada KM, Tuzcu EM, Nissen SE. Ziada KM, et al. Among authors: nissen se. Cardiol Rev. 1999 Sep-Oct;7(5):289-300. doi: 10.1097/00045415-199909000-00014. Cardiol Rev. 1999. PMID: 11208240 Review.

4

Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study.

Kapadia SR, Nissen SE, Ziada KM, Rincon G, Crowe TD, Boparai N, Young JB, Tuzcu EM. Kapadia SR, et al. Among authors: nissen se. J Am Coll Cardiol. 2001 Jul;38(1):206-13. doi: 10.1016/s0735-1097(01)01337-7. J Am Coll Cardiol. 2001. PMID: 11451276 Free article.

5

Application of intravascular ultrasound to characterize coronary artery disease and assess the progression or regression of atherosclerosis.

Nissen SE. Nissen SE. Am J Cardiol. 2002 Feb 21;89(4A):24B-31B. doi: 10.1016/s0002-9149(02)02217-8. Am J Cardiol. 2002. PMID: 11879665 Review.

6

Who is at risk for atherosclerotic disease? Lessons from intravascular ultrasound.

Nissen SE. Nissen SE. Am J Med. 2002 Jun 3;112 Suppl 8A:27S-33S. doi: 10.1016/s0002-9343(02)01087-2. Am J Med. 2002. PMID: 12049992 Review.

7

Coronary atherosclerotic disease burden: an emerging endpoint in progression/regression studies using intravascular ultrasound.

Schoenhagen P, Nissen SE. Schoenhagen P, et al. Among authors: nissen se. Curr Drug Targets Cardiovasc Haematol Disord. 2003 Sep;3(3):218-26. doi: 10.2174/1568006033481401. Curr Drug Targets Cardiovasc Haematol Disord. 2003. PMID: 12871040 Review.

8

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.

Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, Eaton GM, Lauer MA, Sheldon WS, Grines CL, Halpern S, Crowe T, Blankenship JC, Kerensky R. Nissen SE, et al. JAMA. 2003 Nov 5;290(17):2292-300. doi: 10.1001/jama.290.17.2292. JAMA. 2003. PMID: 14600188 Clinical Trial.

9

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN; REVERSAL Investigators. Nissen SE, et al. JAMA. 2004 Mar 3;291(9):1071-80. doi: 10.1001/jama.291.9.1071. JAMA. 2004. PMID: 14996776 Clinical Trial.

10

Pharmacologic strategies for the prevention of atherosclerotic plaque progression.

Schoenhagen P, Crowe T, Tuzcu M, Nissen SE. Schoenhagen P, et al. Among authors: nissen se. Expert Rev Cardiovasc Ther. 2004 Nov;2(6):855-66. doi: 10.1586/14779072.2.6.855. Expert Rev Cardiovasc Ther. 2004. PMID: 15500431 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

570 results

Search Page

Filters